Method Improves the Precision and Speed of Genome Editing
Emmanuelle Charpentier Honored with Nobel Prize For Chemistry
Max Planck Florida joins the chorus of congratulations for Emmanuelle Charpentier who will receive the 2020 Nobel Prize in Chemistry for her groundbreaking work on the CRISPR-Cas9 gene editing technology.
Emmanuelle will share the prize with Jennifer A. Doudna, and they will make history as the only science Nobel ever won by two women. You may have heard Dr. Charpentier speak as part of MPFI's Science Meets Music Series in 2017 (pictured above with Scientific Directors David Fitzpatrick and Ryohei Yasuda). She was also a keynote speaker at our 2017 Sunposium Conference and a guest on MPFI's Neurotransmission Podcast.
In an interview recorded
shortly after the news broke, Emmanuelle tells of her surprise saying it didn't completely hit her until Goran K. Hansson, the secretary-general of the Royal Swedish Academy of Sciences, called her. "I was very emotional, I have to say," says Charpentier, who added "this award obviously underlines the importance and relevance of fundamental research in the field of microbiology” and "it’s not about publishing in high-impact journals. It’s about solid work.”
Considered a recent revolution in the fields of medicine, biotechnology, and agriculture, the CRISPR-Cas9 technology is a powerful and versatile tool to specifically and efficiently modify any genetic sequence in the cells of living organisms. The CRISPR-Cas9 gene editing technology has applications across many diverse fields of science, including human and veterinary medicine, agriculture, and biotechnology. Its broad applicability, versatility, and ease of use are the reasons that it has been so rapidly adopted by the scientific community. While the technology is already waiting in the wings to be marketed in agriculture, the mission in the field of medicine over the next years will be to translate it into safe and effective therapies for serious human diseases for which there are currently no treatment options.